A decrease of mtDNA and TFAM levels in patients and animal models of neurodegenerative disorders such as PD, AD, Huntington’s disease (HD), and ALS has been described (Reviewed in [35]), revealing the involvement of TFAM in neurodegeneration. Here, TFAM is linked to juvenile Huntington disease.